• FirefoxUpgrade to the new Firefox »
  •  Dow Up0.15% Nasdaq Up0.36%

    Northwest Biotherapeutics, Inc. (NWBO)

    -NasdaqCM
    5.74 Up 0.05(0.88%) Dec 19, 4:00PM EST
    |After Hours : 5.74 0.00 (0.00%) Dec 19, 4:48PM EST
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2013Dec 31, 2012Dec 31, 2011
    Total Revenue 809   772   10  
    Cost of Revenue -   -   -  
    Gross Profit 809   772   10  
    Operating Expenses
    Research Development43,906  28,908  13,452  
    Selling General and Administrative12,364  15,675  13,335  
    Non Recurring -   -   -  
    Others12  14  10  
    Total Operating Expenses -   -   -  
    Operating Income or Loss (55,473) (43,825) (26,787)
    Income from Continuing Operations
    Total Other Income/Expenses Net(9,474)(10,053)1,605  
    Earnings Before Interest And Taxes(64,947)(53,878)(25,182)
    Interest Expense842  13,442  7,648  
    Income Before Tax(65,789)(67,320)(32,830)
    Income Tax Expense -   -   -  
    Minority Interest -   -   -  
    Net Income From Continuing Ops(65,789)(67,320)(32,830)
    Non-recurring Events
    Discontinued Operations -   -   -  
    Extraordinary Items -   -   -  
    Effect Of Accounting Changes -   -   -  
    Other Items -   -   -  
    Net Income (65,789) (67,320) (32,830)
    Preferred Stock And Other Adjustments -   -   -  
    Net Income Applicable To Common Shares (65,789) (67,320) (32,830)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.